Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2750 results found
2023 ∙ Jing, X. Han, M. Wang, X. Zhou, L.
SARS-CoV-2 vaccine breakthrough infection in the older adults: a meta-analysis and systematic review
Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Søndergaard, M. H. Thavarajah, J. J. Churchill Henson, H. Wejse, C. M.
SARS-CoV-2 vaccine immunogenicity for people living with HIV: A systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ McNally, K. Roess, A. Weinstein, A. Lindley, L. Wallin, R.
School Nurses' Experiences and Roles in Promoting and Administering the HPV Vaccine: A Systematic Review Using the Socioecological Framework
Healthcare workers Human papillomavirus (HPV) Acceptance
Rating:
Not applicable
2023 ∙ Martins, J. P. Santos, M. Martins, A. Felgueiras, M. Santos, R.
Seasonal Influenza Vaccine Effectiveness in Persons Aged 15-64 Years: A Systematic Review and Meta-Analysis
Adolescents Adults Influenza Efficacy/effectiveness
Rating:
High
2023 ∙ Y. Elzouki, A. N. Elshafei, M. N. Aziz, A. Elzouki, I. Waheed, M. A. Farooqui, K. Azad, A. M. Habas, E. Danjuma, M. I.
Seroconversion and safety of Covid-19 vaccines in patients with chronic liver disease and liver transplant: A systematic review
Adults COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2023 ∙ Gkoufa, A. Lekakis, V. Papatheodoridis, G. Cholongitas, E.
Seroconversion following a booster dose of COVID-19 vaccine in liver transplant recipients. A systematic review and meta-analysis
Adults Older adults COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2023 ∙ Iryaningrum, M. R. Cahyadi, A. Damara, F. A. Bandiara, R. Marbun, M. B. H.
Seroconversion rates in kidney transplant recipients following SARS-CoV-2 vaccination and its association with immunosuppressive agents: a systematic review and meta-analysis
Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Low
2023 ∙ Wang, Y. Chen, D. Pan, Y. Li, H. Zhao, W. Lu, T. Kong, W. Ding, M. Wang, X. Zhang, G.
Serological response and immune-related adverse events following COVID-19 vaccination in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
Adults Older adults COVID-19 Efficacy/effectiveness Safety
Rating:
Low
2023 ∙ Zhou, Q. Zeng, F. Meng, Y. Liu, Y. Liu, H. Deng, G.
Serological response following COVID-19 vaccines in patients living with HIV: a dose-response meta-analysis
Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Mu, Y. Wu, H. Jiang, Z. Liu, K. Xue, X. Zhang, W. Chen, Z.
Serological Responses after a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis
All age groups COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
Loading...